The Latest Breaking News from MHRA

The treatment is the first to be licensed using the gene-editing tool known as Crispr, for which its inventors were awarded the Nobel prize in 2020.

Anastrozole has the potential to reduce the risk of breast cancer by almost 50% for many postmenopausal women at risk, here's what you need to know

Hundreds of fake Ozempic jabs from the black market have been seied by the regulator

Pre-filled injection devices claimed to hold Ozempic or Saxenda may contain other substances, regulator says

Last week, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) had released a report stating that "there have been some suspected reports of new-onset or aggravation of pre-existing myasthenia gravis or ocular myasthenia associated with statin use." Myasthenia gravis is an autoimmune neuromuscular disorder that is characterised by fluctuating…

Vorasidenib worked in trials but is not yet available on the NHS

The condition is caused after the repeated use of steroid creams and tablets commonly prescribed by the NHS, Holly Evans writes

NHS is first health system to offer injection to hundreds of patients which will cut treatment times by up to three quarters

The Information Commissioner’s Office urged organisations to ensure their performance and processes complied with the law.